Circulating pediatric respiratory pathogens in Taiwan during 2020: Dynamic change under low COVID-19 incidence

J Microbiol Immunol Infect. 2022 Dec;55(6 Pt 2):1151-1158. doi: 10.1016/j.jmii.2022.03.005. Epub 2022 Apr 14.

Abstract

Background: In Taiwan, there were only 799 confirmed COVID-19 cases in 2020. The unique backdrop amidst a pandemic and promotion of nonpharmaceutical interventions generated some distinct changes in the epidemiology of common respiratory pathogens. In this study, we aimed to investigate the dynamic changes in respiratory pathogens in children during 2020.

Methods: We performed a retrospective cohort study at a tertiary hospital in southern Taiwan during 2020. Patients aged 0-18 years who visited the pediatric emergency department were enrolled. Children who presented with clinical symptoms (fever or respiratory illness) and received nasopharyngeal swabs for multiplex polymerase chain reaction (PCR) were included in our analysis. We also compared respiratory syncytial virus (RSV) trends from previous years by PCR and lateral flow immunochromatographic assays from 2017 to 2020.

Results: A total of 120 children were tested. The overall detection rate was 55%. With strengthened restrictions, the detection rate dropped from 70% to 30%. However, non-enveloped viruses (rhinovirus/enterovirus and adenovirus) were in constant circulation. Upon easing prevention measures, the detection rate remained above 60%, and an outbreak of an enveloped virus (RSV and parainfluenza virus) was noted. Compared with 2017-2019, the cyclical RSV epidemic was delayed, with a large surge in late 2020.

Conclusions: We observed a constant circulation of non-enveloped viruses when strict nonpharmaceutical interventions were employed and a delayed surge of enveloped viruses during the easing of restrictions. Continuous surveillance and monitoring of the evolutionary dynamics of respiratory viruses is important, while easing restrictions requires balanced judgment.

Keywords: COVID-19; Children; Non-enveloped virus; Nonpharmaceutical interventions; Respiratory syncytial virus.

MeSH terms

  • COVID-19* / epidemiology
  • Child
  • Humans
  • Incidence
  • Infant
  • Multiplex Polymerase Chain Reaction / methods
  • Respiratory Syncytial Virus, Human*
  • Respiratory Tract Infections*
  • Retrospective Studies
  • Taiwan / epidemiology
  • Viruses*